Related Experiment Video
Updated: Oct 16, 2025
Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
Published on: October 28, 2022
Encephalopathy in Preterm Infants: Advances in Neuroprotection With Caffeine
Liu Yang1,2, Xuefei Yu1, Yajun Zhang3
1Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Insights
Caffeine shows promise as a neuroprotective drug for preterm infants, offering benefits through various mechanisms. Its effectiveness in preventing brain injury depends on dosage, developmental stage, and exposure duration.
Area of Science:
- Neonatal neurology
- Pharmacology
- Developmental neuroscience
Background:
- Neonatal rescue technology has improved survival rates for critically ill preterm infants.
- However, this has led to an increased incidence of brain injury and sequelae in survivors.
- Effective neuroprotective strategies for preterm infants remain a critical unmet need.
Purpose of the Study:
- To review the pharmacological characteristics of caffeine.
- To elucidate caffeine's mechanisms of action in preterm infant encephalopathy.
- To discuss the use of caffeine for neuroprotection in this vulnerable population.
Main Methods:
- Review of existing literature on caffeine's pharmacological properties.
- Analysis of studies investigating caffeine's effects on the immature brain.
- Examination of caffeine's mechanisms, including adenosine receptor antagonism and phosphodiesterase inhibition.
Main Results:
- Caffeine exhibits multiple mechanisms of action, including adenosine receptor antagonism, phosphodiesterase inhibition, calcium ion activation, and GABA receptor antagonism.
- Studies indicate both direct and indirect beneficial effects of caffeine on the developing brain.
- The efficacy of caffeine is influenced by dose, developmental stage, and duration of exposure.
Conclusions:
- Caffeine is an emerging neuroprotective agent with recognized benefits for preterm infants.
- Understanding its dose-dependent and stage-specific effects is crucial for optimal application.
- Further research into caffeine's role in preventing and treating preterm brain injury is warranted.
Abstract:
With the improvement in neonatal rescue technology, the survival rate of critically ill preterm infants has substantially increased; however, the incidence of brain injury and sequelae in surviving preterm infants has concomitantly increased. Although the etiology and pathogenesis of preterm brain injury, and its prevention and treatment have been investigated in recent years, powerful and effective neuroprotective strategies are lacking. Caffeine is an emerging neuroprotective drug, and its benefits have been widely recognized; however, its effects depend on the dose of caffeine administered, the neurodevelopmental stage at the time of administration, and the duration of exposure. The main mechanisms of caffeine involve adenosine receptor antagonism, phosphodiesterase inhibition, calcium ion activation, and γ-aminobutyric acid receptor antagonism. Studies have shown that there are both direct and indirect beneficial effects of caffeine on the immature brain. Accordingly, this article briefly reviews the pharmacological characteristics of caffeine, its mechanism of action in the context of encephalopathy in premature infants, and its use in the neuroprotection of encephalopathy in this patient population.
